IP Library Granted Patent US 8,858,432
Granted Patent B2
US 8,858,432 · App. 12/524,837 · Granted Oct 14, 2014

Ingestible event marker systems

Inventors: Timothy Robertson (Belmont, CA); George Savage (Portola Valley, CA); Mark Zdeblick (Portola Valley, CA); Yashar Behzadi (San Francisco, CA); Benedict Costello (Berkeley, CA); Jeremy Frank (San Francisco, CA); Hooman Hafezi (Redwood City, CA); Tariq Haniff (Redwood City, CA); David O'Reilly (Palo Alto, CA)
Assignee: Proteus Digital Health, Inc.
A61B5/0031A61J3/007H04B5/0068H01M6/005H01Q1/273A61B5/6873A61B5/0205A61B5/6846A61B5/0073A61B5/0028A61B2560/0214A61B5/6861A61B5/073Y10S128/903
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,858,432
App. No.
12/524,837
Granted
Oct 14, 2014
Kind
B2
Abstract

Ingestible event marker systems that include an ingestible event marker (i.e., an IEM) and a personal signal receiver are provided. Embodiments of the IEM include an identifier, which may or may not be present in a physiologically acceptable carrier. The identifier is characterized by being activated upon contact with a target internal physiological site of a body, such as digestive tract internal target site. The personal signal receiver is configured to be associated with a physiological location, e.g., inside of or on the body, and to receive a signal the IEM. During use, the IEM broadcasts a signal which is received by the personal signal receiver.

Claims (81)

1. A system comprising:

an ingestible event marker (IEM) composition configured to emit a signal upon contact with a target physiological site and does not include an active agent;

wherein the IEM comprises:

a first battery structure comprising:

a first cathode;

a first anode, wherein the first cathode and the first anode are made at least in part from dissimilar materials selected to provide a voltage potential difference when the first cathode and the first anode contact an electrolyte made up at least in part by fluid present at the target physiological site;

a first chamber containing the first cathode and the first anode, wherein the first chamber defines at least one opening providing for entry and exit from the first chamber of the fluid; and

a second battery structure comprising:

a second cathode;

a second anode, wherein the second cathode and the second anode are made from dissimilar materials selected to provide a voltage potential difference when the second cathode and the second anode contact the electrolyte; and

a second chamber containing the second cathode and the second anode, wherein the second chamber defines at least one opening providing for entry and exit from the second chamber of the fluid; and

a signal receiver configured to receive a signal produced by the IEM, wherein the receiver is sized to be stably associated with a living subject in a manner that does not substantially impact movement of said living subject.

2. The system according to claim 1 , wherein the IEM composition comprises an integrated circuit that includes a signal generation element.

3. The system according to claim 2 , wherein the IEM composition further comprises a solid support that includes the integrated circuit, and wherein the first and second battery structures are present on a surface of the solid support.

4. The system according to claim 1 , wherein the signal receiver comprises at least one electrode.

5. The system according to claim 1 , wherein the signal receiver comprises two electrodes.

6. The system according to claim 1 , wherein the signal receiver further comprises a power generation element.

7. The system according to claim 1 , wherein the signal receiver further comprises a data storage element.

8. The system according to claim 1 , wherein the signal receiver further comprises a physiological sensor.

9. The system according to claim 8 , wherein the physiological sensor is configured to provide data selected from the group consisting of respiration, heart rate, temperature and blood pressure.

10. The system according to claim 1 , wherein the signal receiver comprises:

first and second electrodes configured to receive a signal;

a signal demodulator;

a signal transmitter;

a data storage element; and

a power source.

11. The system according to claim 10 , wherein the signal receiver comprises an integrated circuit that comprises at least one of the elements selected from the group consisting of:

the first and second electrodes configured to receive a signal;

the signal demodulator;

the signal transmitter; and

the data storage element.

12. The system according to claim 11 , wherein the signal receiver further comprises a clock element.

13. The system according to claim 12 , wherein the signal receiver further comprises a preamplifier.

14. The system according to claim 13 , wherein the signal receiver further comprises a microprocessor.

15. The system according to claim 10 , wherein the first and second electrodes are configured to receive a signal and to sense a biomarker.

16. The system according to claim 15 , wherein the biomarker is selected from the group consisting of electrocardiogram, heart rate, respiration rate and fluid status.

17. The system according to claim 15 , wherein the signal receiver further comprises a physiological sensor distinct from the first and second electrodes.

18. The system according to claim 17 , wherein the physiological sensor distinct from the first and second electrodes is selected from the group consisting of temperature sensor, pressure sensor and analyte detector, motion sensor or a strain gauge.

19. The system according claim 1 , wherein the system further comprises an external data receiver configured to receive data from the signal receiver.

20. The system according to claim 19 , wherein the external data receiver further comprises at least one of a data storage element, a data processing element, a data display element, data transmission element, a notification mechanism, and a user interface.

21. The system according to claim 20 , wherein the external data receiver is selected from the group consisting of a bedside monitor, a PDA, a cell phone and a PC.

22. An ingestible event marker (IEM) composition configured to emit a signal upon contact with a target physiological site and does not include an active agent, wherein the IEM comprises:

a first battery structure comprising:

a first cathode;

a first anode, wherein the first cathode and the first anode are made at least in part from dissimilar materials selected to provide a voltage potential difference when the first cathode and the first anode contact an electrolyte made up at least in part by fluid present at the target physiological site;

a first chamber containing the first cathode and the first anode, wherein the first chamber defines at least one opening providing for entry and exit from the first chamber of the fluid; and

a second battery structure comprising:

a second cathode;

a second anode, wherein the second cathode and the second anode are made from dissimilar materials selected to provide a voltage potential difference when the second cathode and the second anode contact the electrolyte; and

a second chamber containing the second cathode and the second anode, wherein the second chamber defines at least one opening providing for entry and exit from the second chamber of the fluid.

23. A signal receiver configured to receive a signal produced by an identifier of a pharmaceutical composition upon contact with a target physiological site and sized to be stably associated with a living subject in a manner that does not substantially impact movement of said living subject, wherein the identifier comprises:

a first battery structure comprising:

a first cathode;

a first anode, wherein the first cathode and the first anode are made at least in part from dissimilar materials selected to provide a voltage potential difference when the first cathode and the first anode contact an electrolyte made up at least in part by fluid present at the target physiological site;

a first chamber containing the first cathode and the first anode, wherein the first chamber defines at least one opening providing for entry and exit from the first chamber of the fluid; and

a second battery structure comprising:

a second cathode;

a second anode, wherein the second cathode and the second anode are made from dissimilar materials selected to provide a voltage potential difference when the second cathode and the second anode contact the electrolyte; and

a second chamber containing the second cathode and the second anode, wherein the second chamber defines at least one opening providing for entry and exit from the second chamber of the fluid.

24. A method comprising:

administering to a subject an ingestible event marker (IEM) configured to emit a signal upon contact with a target physiological site and does not include an active agent, wherein the IEM comprises:

a first battery structure comprising:

a first cathode;

a first anode, wherein the first cathode and the first anode are made at least in part from dissimilar materials selected to provide a voltage potential difference when the first cathode and the first anode contact an electrolyte made up at least in part by fluid present at the target physiological site;

a first chamber containing the first cathode and the first anode, wherein the first chamber defines at least one opening providing for entry and exit from the first chamber of the fluid; and

a second battery structure comprising:

a second cathode;

a second anode, wherein the second cathode and the second anode are made from dissimilar materials selected to provide a voltage potential difference when the second cathode and the second anode contact the electrolyte; and

a second chamber containing the second cathode and the second anode, wherein the second chamber defines at least one opening providing for entry and exit from the chamber of the fluid; and

detecting a signal emitted from said identifier with a signal receiver.

25. A kit comprising:

an ingestible event marker (IEM) configured to emit a signal upon contact with a target physiological site and does not include an active agent, wherein the IEM comprises:

a first battery structure comprising:

a first cathode;

a first anode, wherein the first cathode and the first anode are made at least in part from dissimilar materials selected to provide a voltage potential difference when the first cathode and the first anode contact an electrolyte made up at least in part by fluid present at the target physiological site;

a first chamber containing the first cathode and the first anode, wherein the first chamber defines at least one opening providing for entry and exit from the first chamber of the fluid; and

a second battery structure comprising:

a second cathode;

a second anode, wherein the second cathode and the second anode are made from dissimilar materials selected to provide a voltage potential difference when the second cathode and the second anode contact the electrolyte; and

a second chamber containing the second cathode and the second anode, wherein the second chamber defines at least one opening providing for entry and exit from the chamber of the fluid; and

a signal receiver.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2024
From: PROTEUS DIGITAL HEALTH INC.,
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 068980/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2024
From: OTSUKA AMERICA PHARMACEUTICAL, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 068980/0277 →
CHANGE OF NAME Recorded Nov 2, 2012
From: PROTEUS BIOMEDICAL, INC.
To: PROTEUS DIGITAL HEALTH, INC.
Reel/Frame 029228/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2009
From: ROBERTSON, TIMOTHY; SAVAGE, GEORGE; ZDEBLICK, MARK; BEHZADI, YASHAR; COSTELLO, BENEDICT; FRANK, JEREMY; HAFEZI, HOOMAN; HANIFF, TARIQ; O'REILLY, DAVID
To: PROTEUS BIOMEDICAL, INC.
Reel/Frame 023160/0001 →
Continuity (9)
Provisional Application 60877780 · Feb 1, 2007
Provisional Application 60889871 · Feb 14, 2007
Provisional Application 60889868 · Feb 14, 2007
Provisional Application 60949198 · Jul 11, 2007
Provisional Application 60949223 · Jul 11, 2007
Provisional Application 60949208 · Jul 11, 2007
Provisional Application 60956694 · Aug 18, 2007
Provisional Application 60941444 · Jun 1, 2007
Related Publication 20100185055A1 · Jul 22, 2010